Top compounds associated with response to SPRR2E


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA Imatinib CTRPv2 pan-cancer AAC -0.021 0.6
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.02 0.6
mRNA NSC-87877 GDSC1000 pan-cancer AAC -0.02 0.6
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.018 0.6
mRNA CGP-082996 GDSC1000 pan-cancer AAC -0.029 0.6
mRNA embelin GDSC1000 pan-cancer AAC 0.02 0.6
mRNA Merck60 CTRPv2 pan-cancer AAC 0.017 0.6
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.029 0.6
Download CSV